This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

For patients with asymptomatic severe aortic stenosis, transcatheter aortic valve replacement was superior to clinical ...

Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.

University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.

a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without symptoms. The approval is the first for TAVR in asymptomatic patients. In the EARLY TAVR ...